Major Institutional
- A02 - Agentes para el tratamiento de alteraciones causadas por ácidos
- OMEPRAZOLE MAJOR gastro-resistant capsule, hard 20 mg
- RANITIDINE HCL film-coated tablet 150 mg
- RANITIDINE HCL film-coated tablet 300 mg
- D06 - Antibióticos y quimioterápicos para uso dermatológico
- ACYCLOVIR MYLAN ointment 5%
- L01 - Antineoplásicos
- CARBOPLATIN MYLAN concentrate for solution for infusion 150 mg/15 ml
- CARBOPLATIN MYLAN concentrate for solution for infusion 450 mg/45 ml
- CARBOPLATIN MYLAN concentrate for solution for infusion 50 mg/5 ml
- CARBOPLATIN MYLAN concentrate for solution for infusion 600 mg/60 ml
- L02 - Terapia endocrina
- ESTROPIPATE tablet 3 mg
- M01 - Antiinflamatorios y antirreumáticos
- ETODOLAC capsule, hard 200 mg
- ETODOLAC capsule, hard 300 mg
- IBUPROFEN coated tablet 400 mg
- IBUPROFEN film-coated tablet 600 mg
- IBUPROFEN prolonged-release tablet 800 mg
- IBUPROFEN tablet 200 mg
- OXAPROZIN tablet 600 mg
- N05 - Psicolépticos
- FLUPHENAZINE HCL tablet 10 mg
- V03 - Todos los demás preparados terapéuticos
- FLUMAZENIL MYLAN solution for injection 0.5 mg/5 ml
- FLUMAZENIL MYLAN solution for injection 1 mg/10 ml